Troya Therapeutics ApS
Private limited companyCVR 44032589København NActive
Troya Therapeutics ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2023. Equity was negative at the end of 2025 (−DKK 6.4m). The company made a loss in both 2024 and 2025, most recently DKK 4.6m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 1.4m to DKK 4.6m (2024 → 2025).
Employees
- 1 more employees than a year earlier: 5 (07/2026) against 4 (07/2025).
Management and owners, last 24 months
- New in management: Christian Grøndahl (board member, 22/12/2025) and Austin Wayne Boesch (ceo, 01/08/2026).
- Stepped down: Jan Johannes Enghild (board member, 22/12/2025) and Sean Dean Lykke Harwood (director, 01/08/2026).
- New owners registered: Ulrik Bjerl Nielsen (07/03/2025) and Austin Wayne Boesch (07/03/2025).
- No longer registered as owner: Ulrik Bjerl Nielsen (06/03/2025).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | −421 | −991 | −2,382 | −140.2% |
| Operating profit (EBIT) | −421 | −1,350 | −5,356 | −296.8% |
| Profit before tax | −459 | −1,525 | −5,831 | −282.5% |
| Net profit | −359 | −1,441 | −4,638 | −221.9% |
| Total assets | 1,133 | 3,944 | 9,932 | +151.8% |
| Equity | −319 | −1,760 | −6,398 | −263.5% |
| Liabilities | 1,452 | 5,704 | 16,331 | +186.3% |
| Cash and cash equivalents | 994 | 3,547 | 8,291 | +133.8% |
| Average number of employees | 0 | 0 | 4 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 6.4m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 04/02/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 24/04/2025 | The company | PDF not statedXBRL |
| 2023 | 24/04/2023 – 31/12/2023 | 28/06/2024 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,268of 69,742 Better than 1% | No. 69,346of 69,964 Better than 1% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 273of 323 Better than 16% | No. 295of 329 Better than 10% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,452of 16,614 Better than 1% | No. 16,536of 16,661 Better than 1% |
| All companies of type ApS66,508 companies in the comparison | No. 65,993of 66,379 Better than 1% | No. 65,887of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Troya Therapeutics ApS−DKK 2.4m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Troya Therapeutics ApS−DKK 4.6m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Troya Therapeutics ApS−DKK 6.4m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Troya Therapeutics ApS5
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Seandean Lykke Harwood Holding ApS25%
- EnghildThøgersen Holding ApS20%
- Ulrik Bjerl Nielsen33.33%
- Austin Wayne Boesch10%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Austin Wayne Boesch | CEO | 01/08/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Ulrik Bjerl Nielsen | Chair of the board | 24/04/2023 |
| Sean Dean Lykke Harwood | Board member | 24/04/2023 |
| Christian Grøndahl | Board member | 22/12/2025 |
- Founders
- Ulrik Bjerl Nielsen, Seandean Lykke Harwood Holding ApS, EnghildThøgersen Holding ApS
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Jan Johannes Enghild | Board member | 24/04/2023 | 22/12/2025 |
| Sean Dean Lykke Harwood | Director | 24/04/2023 | 01/08/2026 |
Signing rule: Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsOle Maaløes Vej 3
2200 København N
København Municipality · Postcode 2200
Other companies at the address (8)
- BII Holdings A/SOther financial service activities n.e.c.
- Skape Bio ApSResearch and experimental development on natural sciences and engineering
- Agrobiomics ApSResearch and experimental development on natural sciences and engineering
- Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
- BioColor ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Troya Therapeutics ApS | Ole Maaløes Vej 3, 2200 København N | 6 | 1029282761 |
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
The purpose is quoted from the register in Danish.
Changes year by year
20 registered events20263 changesmanagement 2 · accounts 1
- ManagementAustin Wayne Boesch appointed ceo
- ManagementSean Dean Lykke Harwood stepped down as director
- AccountsAnnual report for 2025 published
20257 changesmanagement 2 · accounts 1 · ownership 3 · industry 1
- ManagementChristian Grøndahl appointed board member
- ManagementJan Johannes Enghild stepped down as board member
- AccountsAnnual report for 2024 published
- OwnershipUlrik Bjerl Nielsen registered as owner (33.33%)
- OwnershipAustin Wayne Boesch registered as owner (10%)
- OwnershipUlrik Bjerl Nielsen is no longer registered as owner
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesaddress 1 · accounts 1
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
- AccountsAnnual report for 2023 published
20238 changesfounded 1 · management 4 · ownership 3
- FoundedRegistered as Troya Therapeutics ApS
- ManagementJan Johannes Enghild appointed board member
- ManagementSean Dean Lykke Harwood appointed director
- ManagementUlrik Bjerl Nielsen appointed chair of the board
- ManagementSean Dean Lykke Harwood appointed board member
- OwnershipUlrik Bjerl Nielsen registered as owner (50%)
- OwnershipSeandean Lykke Harwood Holding ApS registered as owner (25%)
- OwnershipEnghildThøgersen Holding ApS registered as owner (20%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Zealand Pharma A/Svia Christian Grøndahl
- Vitrolife A/Svia Christian Grøndahl
- SNIPR Biome ApSvia Christian Grøndahl
- SeeQ Diagnostics ApSvia Christian Grøndahl
- UNIKUM Therapeutics ApSvia Ulrik Bjerl Nielsen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.